최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, v.16 no.14, 2002년, pp.1988 - 1990
Wook Kang, Keon (National Research LaboratorySeoul National University Seoul Korea) , Gyoon Kim, Yoon (National Research LaboratorySeoul National University Seoul Korea) , Kyong Cho, Min (National Research LaboratorySeoul National University Seoul Korea) , Kyung Bae, Soo (College of Pharmacy and Research Institute of Pharmaceutical SciencesSeoul National University Seoul Korea) , Won Kim, Choon (Department of Clinical PathologyHanyang University Medical School Seoul Korea) , Gull Lee, Myung (National Research LaboratorySeoul National University Seoul Korea) , Geon Kim, Sang (National Research LaboratorySeoul National University Seoul Korea)
Liver cirrhosis (LC) is a chronic disease with high mortality rate. In the United States and Western world as well as Asian countries, LC is the major leading cause of death by disease. Yet, no effective therapeutic agent is available for LC treatment. Laboratory cirrhotic rats produced by dimethyln...
National Institute on Alcohol Abuse and Alcoholism; Surveillance Report #41 DeBakey S. F. 1996 Liver cirrhosis mortality in the United States, 1970-1993
National Institute on Alcohol Abuse and Alcoholism; Surveillance Report #57 Yoon Y. 2001 Liver cirrhosis mortality in the United States, 1970-1998
Cancer Statistics in Japan 1999 Kakizoe T. 1999
Corpechot, Christophe, Carrat, Fabrice, Bonnand, Anne-Marie, Poupon, Renée Eugénie, Poupon, Raoul. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.32, no.6, 1196-1199.
Parés, Albert, Caballería, Llorenç, Rodés, Juan, Bruguera, Miquel, Rodrigo, Luis, García-Plaza, Antonio, Berenguer, Joaquín, Rodríguez-Martínez, Dolores, Mercader, José, Velicia, Rosario. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.32, no.4, 561-566.
Goulis, John, Leandro, Gioacchino, Burroughs, Andrew K. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. The Lancet, vol.354, no.9184, 1053-1060.
Neuberger, James. Urso-panacea or placebo?. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.31, no.4, 1027-1028.
Pares, A., Planas, R., Torres, M., Caballeria, J., Viver, J.M., Acero, D., Panes, J., Rigau, J., Santos, J., Rodes, J.. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.28, no.4, 615-621.
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.34, no.2, 411-416.
Ueki, Takahiro, Kaneda, Yasufumi, Tsutsui, Hiroko, Nakanishi, Kenji, Sawa, Yoshiki, Morishita, Ryuichi, Matsumoto, Kunio, Nakamura, Toshikazu, Takahashi, Hiroshi, Okamoto, Eizo, Fujimoto, Jiro. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature medicine, vol.5, no.2, 226-230.
Wattenberg, L W, Bueding, E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard.. Carcinogenesis, vol.7, no.8, 1379-1381.
Ansher, Sherry S., Dolan, Patrick, Bueding, Ernest. Chemoprotective Effects of Two Dithiolthiones and of Butylhydroxyanisole Against Carbon Tetrachloride and Acetaminophen Toxicity. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.3, no.6, 932-935.
Cancer Res Bolton M. G. 3499 53 1993 Transient intervention with oltipraz protects against aflatoxin‐induced hepatic tumorigenesis
Cancer Epidemiol. Biomarkers Prev Jacobson L. P. 257 6 1997 Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes
Wang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., Jacobson, L. P., Munoz, A., Helzlsouer, K. J., Groopman, J. D., Kensler, T. W.. Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China. Journal of the National Cancer Institute: JNCI, vol.91, no.4, 347-354.
Cancer Res Kensler T. W. 4271 47 1987 Mechanism of protection against aflatoxin tumorigenicity in rats fed 5‐(2‐pyrazinyl)‐4‐methyl1, 2‐dithiol‐3‐thione (oltipraz) and related 1, 2‐dithiol‐3‐thiones and 1, 2‐dithiol‐3‐ones
Langouët, S, Mahéo, K, Berthou, F, Morel, F, Lagadic-Gossman, D, Glaise, D, Coles, B, Ketterer, B, Guillouzo, A. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.. Carcinogenesis, vol.18, no.7, 1343-1349.
Albanis, Efsevia, Friedman, Scott L.. HEPATIC FIBROSIS. Clinics in liver disease, vol.5, no.2, 315-334.
Yamazaki, H, Inui, Y, Yun, C H, Guengerich, F P, Shimada, T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.. Carcinogenesis, vol.13, no.10, 1789-1794.
Yamazaki, H, Oda, Y, Funae, Y, Imaoka, S, Inui, Y, Guengerich, F P, Shimada, T. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).. Carcinogenesis, vol.13, no.6, 979-985.
Tsukamoto, H, Matsuoka, M, French, S W. Experimental models of hepatic fibrosis: a review.. Seminars in liver disease, vol.10, no.1, 56-65.
Kang, Keon Wook, Choi, Sung Hee, Ha, Jong Ryul, Kim, Choon Won, Kim, Sang Geon. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-β1 and tumor necrosis factor-α expression. Chemico-biological interactions, vol.139, no.1, 61-77.
Flier, Jeffrey S., Underhill, Lisa H., Friedman, Scott L.. The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies. The New England journal of medicine, vol.328, no.25, 1828-1835.
Qi, Zhe, Atsuchi, Nobuhiko, Ooshima, Akira, Takeshita, Akira, Ueno, Hikaru. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proceedings of the National Academy of Sciences of the United States of America, vol.96, no.5, 2345-2349.
A comparison of four connective tissue staining methods. Acta. Pathol. Microbiol. Immunol. Scand Vyberg M. 11 95 1987 Detection of early zone 3 liver fibrosis in chronic alcoholics
Anal. Quant. Cytol. Histol Moragas A. 169 20 1998 Characteristics of perisinusoidal collagenization in liver cirrhosis: Computer‐assisted quantitative analysis
Friedman, Scott L., Rockey, Don C., McGuire, Richard F., Maher, Jacquelyn J., Boyles, Janet K., Yamasaki, Glenn. Isolated hepatic lipocytes and kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.15, no.2, 234-243.
Voth, Daniel E., Heinzen, Robert A.. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cellular microbiology, vol.9, no.4, 829-840.
Kim, Sang Geon, Nam, Seon Young, Kim, Choon Won, Kim, Jeong Hee, Cho, Chul Koo, Yoo, Seong Yul. Enhancement of Radiation-Inducible Hepatic Glutathione-S-TransferasesYa,Yb1,Yb2,Yc1, andYc2Gene Expression by Oltipraz: Possible Role in Radioprotection. Molecular pharmacology, vol.51, no.2, 225-233.
Piette, J, Hirai, S, Yaniv, M. Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts.. Proceedings of the National Academy of Sciences of the United States of America, vol.85, no.10, 3401-3405.
Kang, Keon Wook, Ryu, Ji Hwa, Kim, Sang Geon. The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells. Molecular pharmacology, vol.58, no.5, 1017-1025.
Nancy, Vanessa, Wolthuis, Rob M.F., de Tand, Marie-France, Janoueix-Lerosey, Isabelle, Bos, Johannes L., de Gunzburg, Jean. Identification and Characterization of Potential Effector Molecules of the Ras-related GTPase Rap2. The Journal of biological chemistry, vol.274, no.13, 8737-8745.
Wagner, Andreas H., Krzesz, Robert, Gao, Dingcheng, Schroeder, Christian, Cattaruzza, Marco, Hecker, Markus. Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells. Molecular pharmacology, vol.58, no.6, 1333-1340.
Henriksen, Jens H., Stage, Jens G., Schlichting, Poul, Winkler, Kjeld. Intraperitoneal pressure: ascitic fluid and splanchnic vascular pressures, and their role in prevention and formation of ascites. Scandinavian journal of clinical & laboratory investigation, vol.40, no.6, 493-501.
Mathews, Michael B., Bernstein, Robert M., Franza Jr, B. Robert, Garrels, James I.. Identity of the proliferating cell nuclear antigen and cyclin. Nature, vol.309, no.5966, 374-376.
Hautekeete, Marc L., Geerts, Albert. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Archiv : an international journal of pathology, vol.430, no.3, 195-207.
Tsitologiia Kiiasov A.P. 876 40 1998 Contact inhibition of desmin expression in rat liver Ito cells in vitro
Krüse, Jacqueline J.C.M., Bart, Cindy I., Leer, Jan-Willem H., Wondergem, Jan. DETECTION AND QUANTITATIVE MEASUREMENT OF TRANSFORMING GROWTH FACTOR-β1 (TGF-β1) GENE EXPRESSION USING A SEMI-NESTED COMPETITIVE PCR ASSAY. Cytokine, vol.11, no.2, 179-185.
Kidney Int Mizuno S. 937 57 2000 10.1038/sj.ki.4491416 Reciprocal balance of hepatocyte growth factor and transforming growth factor‐β1 in renal fibrosis in mice
GenBank access# AF249327 Yoon G. 2000 5'‐Flanking region of rat TGF‐β1 gene
LUO, JIING‐CHYUAN, HWANG, SHINN‐JANG, LAI, CHIUNG‐RU, LU, CHING‐LIANG, LI, CHUNG‐PIN, TSAY, SHYH‐HAW, WU, JAW‐CHING, CHANG, FULL‐YOUNG, LEE, SHOU‐DONG. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. Journal of gastroenterology and hepatology, vol.13, no.7, 685-690.
Am. J. Gastroenterol Matsuzaki Y. 15 85 1990 Improvement of biliary enzyme levels and itching as a result of long‐term administration of ursodeoxycholic acid in primary biliary cirrhosis
A preliminary report. J. Hepatol Nomura F. 65 11 1990 10.1016/0168-8278(90)90273-T Detection of malotilate toxicity in vitro with peripheral blood mononuclear cells as targets
Baroni, G., D'Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A., Benedetti, A.. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.23, no.5, 1189-1199.
Pinzani, Massimo, Marra, Fabio, Carloni, Vinicio. Signal transduction in hepatic stellate cells. Liver, vol.18, no.1, 2-13.
Tsukamoto, Hidekazu. Cytokine Regulation of Hepatic Stellate Cells in Liver Fibrosis. Alcoholism: clinical and experimental research, vol.23, no.5, 911-911.
Skrtic, Stanko, Wallenius, Kristina, Sjögren, Klara, Isaksson, Olle G.P., Ohlsson, Claes, Jansson, John-Olov. Possible Roles of Insulin-Like Growth Factor in Regulation of Physiological and Pathophysiological Liver Growth. Hormone research, vol.55, no.suppl1, 1-6.
Clouthier, D E, Comerford, S A, Hammer, R E. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.. The Journal of clinical investigation, vol.100, no.11, 2697-2713.
George, Joseph, Chandrakasan, Gowri. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochimica et biophysica acta, Protein structure and molecular enzymology, vol.1292, no.2, 215-222.
J. Biol. Chem Inagaki Y. 276 2001 10.1074/jbc.M010485200 Interaction between GC box binding factors and Smad proteins modulates cell lineage‐specific alpha 2(I) collagen gene transcription
10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S
Iraburu, María J., Domínguez-Rosales, José A., Fontana, Luis, Auster, Anitra, García-Trevijano, Elena R., Covarrubias-Pinedo, Amador, Rivas-Estilla, Ana María, Greenwel, Patricia, Rojkind, Marcos. Tumor necrosis factorα down-regulates expression of theα1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ- and C/EBPδ-dependent mechanism. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.31, no.5, 1086-1093.
Greenwel, Patricia, Tanaka, Shizuko, Penkov, Dmitri, Zhang, Wen, Olive, Michelle, Moll, Jonathan, Vinson, Charles, Di Liberto, Maurizio, Ramirez, Francesco. Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins. Molecular and cellular biology, vol.20, no.3, 912-918.
J. Biol. Chem Zauberman A. 276 2001 10.1074/jbc.M005813200 Smad proteins suppress CCAAT/enhancerbinding protein (C/EBP)β‐ and STAT3‐mediated transcriptional activation of the haptoglobin promoter
Cancer Res Rao C. V. 2502 53 1993 Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats
Cell. Biochem Kensler T. W. 101 22 1995 10.1002/jcb.240590813 Oltipraz: Clinical opportunities for cancer chemoprevention, J
Mol. Pharmacol Prochaska H. J. 15 48 1995 Inhibition of human immunodeficiency virus type 1 replication by 7‐methyl‐6, 8‐bis(methylthio)pyrrolo[1, 2a]pyrazine, an in vivo metabolite of oltipraz
Crowell, J.A., Page, J.G., Rodman, L.E., Heath, J.E., Goldenthal, E.I., Hall, L.B., Kelloff, G.J.. Chronic Toxicity Studies of 5-(2-Pyrazinyl)-4-methyl-1,2-dithiole- 3-thione, a Potential Chemopreventive Agent. Fundamental and applied toxicology : official journal of the Society of Toxicology, vol.35, no.1, 9-21.
Ann. Trop. Med. Parasitol El Tayeb M. 53 82 1988 10.1080/00034983.1988.11812208 Praziquantel and oltipraz: The treatment of school children infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan
※ AI-Helper는 부적절한 답변을 할 수 있습니다.